Valuation: Kenvue Inc.

Market Cap 36.44B 31.88B 29.44B 27.11B 51.07B 3,508B 52.33B 351B 138B 1,718B 137B 134B 5,918B P/E 2026 *
19.9x
P/E 2027 * 17.8x
Enterprise Value 43.85B 38.36B 35.42B 32.62B 61.44B 4,221B 62.96B 422B 166B 2,068B 165B 161B 7,121B EV / Sales 2026 *
2.81x
EV / Sales 2027 * 2.7x
Free-Float
98.9%
Yield 2026 *
4.47%
Yield 2027 * 4.57%
1 day-0.21%
1 week-2.57%
Current month-0.68%
1 month+4.75%
3 months+7.78%
6 months+10.35%
Current year+10.03%
1 week 18.58
Extreme 18.58
19.86
1 month 17.86
Extreme 17.855
20.13
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
22.87
3 years 14.02
Extreme 14.02
25.23
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap.
6/29/26
Starboard Value LP
OtherCompany 1,413 0.0001%
6/29/26 Free

Director

1,413 0.0001%
6/10/26 Sell

Chief Financial Officer

-3,700 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.21%-2.57%-13.73%-23.50% 36.44B
-1.00%+2.00%-3.30%+0.48% 349B
+0.92%+1.61%-6.45%+3.44% 135B
-1.16%+0.80%+7.07%+22.60% 74.4B
+2.16%-0.32%-13.89%-20.09% 52.31B
-0.86%-0.64%-5.83%-56.36% 29.71B
+4.09%+1.76%+15.15%-0.04% 19.89B
-0.70%+2.03%-26.11%-31.23% 19.85B
+0.70%+2.76%-1.17%+27.48% 18.43B
+1.34%-1.52%-14.34%+2.87% 11.39B
Average +0.53%+0.59%-6.26%-7.43% 74.7B
Weighted average by Cap. -0.18%+1.28%-4.42%-1.81%

Financials

2026 *2027 *
Net sales 15.63B 13.67B 12.62B 11.63B 21.9B 1,504B 22.44B 150B 59.33B 737B 58.68B 57.39B 2,537B 16.02B 14.02B 12.94B 11.92B 22.45B 1,542B 23.01B 154B 60.83B 755B 60.16B 58.84B 2,602B
Net income 1.84B 1.61B 1.49B 1.37B 2.58B 177B 2.65B 17.75B 7B 86.9B 6.92B 6.77B 299B 2.06B 1.81B 1.67B 1.54B 2.89B 199B 2.96B 19.88B 7.84B 97.36B 7.75B 7.58B 335B
Net Debt 7.41B 6.48B 5.98B 5.51B 10.38B 713B 10.64B 71.32B 28.12B 349B 27.81B 27.2B 1,203B 6.81B 5.96B 5.5B 5.07B 9.54B 656B 9.78B 65.59B 25.86B 321B 25.58B 25.01B 1,106B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-07-17 US$18.98 -0.21% 29,311,427
26-07-16 US$19.02 +1.71% 15,950,710
26-07-15 US$18.70 -0.32% 18,492,278
26-07-14 US$18.76 -2.44% 19,474,126
26-07-13 US$19.23 -1.28% 39,873,974
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
18.98USD
Average target price
19.75USD
Spread / Average Target
+4.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock